Tuesday, Jan 14, 2025 · SEC filings
What the smart money revealed on Jan 14
415 insider filings came in. We hid 60 planned (10b5-1) sellers and 273 people whose filings were routine, like grants and tax withholding.
Norris Industries (NRIS) Chairman Patrick Norris bought $1.39M
17.36M shares on the open market. Not a grant or an option exercise.
Avadel Pharmaceuticals (AVDL) Director Eric Ende bought $235K
30,000 shares on the open market. Not a grant or an option exercise.
Generation Bio (GBIO) Director Anthony Quinn bought $203K
210,791 shares on the open market. Not a grant or an option exercise.
Lamb Weston (LW) Director Robert Niblock bought $183K
3,000 shares on the open market. Not a grant or an option exercise.
Jabil (JBL) Director Steven Raymund sold $3.03M
Not marked as a planned 10b5-1 sale. Sold 14% of the shares they held directly. Still holds 119,108 shares.
Argan (AGX) Director Peter Getsinger sold $1.34M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 11,792 shares directly.
FedEx (FDX) Director Susan Schwab sold $1.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 8,904 shares directly.
Show 12 more real buys
Show 41 more real sales
13F season
Holdings as of Dec 31, 2024 are due Feb 14
81 funds have filed so far. 58 filed for the quarter before.
Biggest real insider buys, Jan 8–14
Open-market buys by officers and directors, filed in the 7 days up to Jan 14.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.